More biomarkers are necessary for the differential diagnosis of Cushing’s syndrome subtypes in children and adolescents, as well as to predict disease progression more effectively — allowing for quicker and less invasive assessments of patients. That’s according to the results of a new, large, observational study, which also reported on…
After receiving the approval of ketoconazole for the treatment of Cushing’s syndrome patients in the European Union, HRA Pharma is setting up to conduct a post-approval observation study that will closely monitor patients receiving the therapy for any adverse events. The study is part of the mandatory pharmacovigilance…
Treatment with metyrapone rapidly reduces cortisol levels in Cushing’s syndrome patients and keeps them low over the long term, a real-life study shows. The study, “Metyrapone treatment in Cushing’s syndrome: a real-life study,” was published in the journal Endocrine. Cushing’s syndrome is a condition where patients have too much cortisol…
Cushing’s syndrome patients who have adrenal insufficiency have increased risk of death due to disease-related complications, rather than adrenal crisis or adverse occurrences, an observational study suggests. The study, “Mortality data from the European Adrenal Insufficiency Registry—Patient characterization and associations,” was published in the journal Clinical…
Get regular updates to your inbox.